<p>邁阿密，佛羅里達州，2026 年 2 月 26 日（全球新聞通訊社）——Soren Acquisition Corp.（納斯達克代碼：SORNU）（以下簡稱 “公司”）今天宣佈，自 2026 年 2 月 27 日起，公司首次公開募股中發行的單位（以下簡稱 “單位”）的持有者，每個單位由一股面值為 0.0001 美元的公司 A 類普通股（以下簡稱 “A 類普通股”）和三分之一的可贖回認股權證（每個稱為 “認股權證”）組成，持有者可以選擇單獨交易單位中包含的 A 類普通股和認股權證。分離單位時不會發行任何零碎的認股權證，只有完整的認股權證可以交易。A 類普通股和認股權證將在納斯達克全球市場上分別以 “SORN” 和 “SORNW” 作為交易代碼進行交易。未分離的單位將繼續在納斯達克全球市場上以 “SORNU” 作為交易代碼進行交易。</p>
<p>BTIG, LLC 擔任此次發行的唯一賬簿管理人。</p>
<p>本新聞稿不構成出售公司證券的要約或購買證券的邀請，也不應在任何州或司法管轄區內進行這些證券的銷售，若該要約、邀請或銷售在任何此類州或司法管轄區內在未註冊或未獲得資格的情況下是非法的。</p>
<p><strong>關於 Soren Acquisition Corp.</strong></p>
<p>公司是一家空白支票公司，成立的目的是進行與一個或多個企業的合併、聯合、股份交換、資產收購、股份購買、重組或類似的商業組合。公司可以在任何業務或行業或其公司發展階段追求收購機會，但專注於與醫療行業內具有吸引力的目標企業完成商業組合。</p>
<p>公司的管理團隊由首席執行官 Arghavan Di Rezze 和首席財務官 Jamie Weber 領導，他們都是公司董事會（以下簡稱 “董事會”）的成員。此外，董事會還包括 Marc Mazur、Charles N. Khan III 和 Spencer Gerrol。Peter Ondishin 和 Nicholas Shekerdemian 擔任公司的顧問。</p>
<p><strong>前瞻性聲明</strong></p>
<p>本新聞稿可能包含，並且公司代表不時作出的口頭聲明可能包含，根據 1933 年證券法第 27A 條及 1934 年證券交易法第 21E 條的定義的 “前瞻性聲明”。關於可能的商業組合及其融資的聲明，以及本新聞稿中包含的所有其他非歷史事實的聲明均為前瞻性聲明。當在本新聞稿中使用 “預期”、“相信”、“繼續”、“可能”、“估計”、“期望”、“打算”、“可能”、“計劃”、“潛在”、“預測”、“項目”、“應該”、“會” 等詞語時，均與我們或我們的管理團隊相關，標識前瞻性聲明。這些前瞻性聲明基於管理層的信念，以及公司管理層所做的假設和當前可用的信息。實際結果可能因某些因素而與前瞻性聲明所設想的結果有實質性差異，這些因素在公司向證券交易委員會（“SEC”）提交的文件中有詳細説明。所有後續的書面或口頭前瞻性聲明，歸因於我們或代表我們行事的人，均完全受本段的限制。前瞻性聲明受多種條件的制約，其中許多超出了公司的控制，包括在公司向 SEC 提交的首次公開募股註冊聲明和招股説明書的風險因素部分中列出的條件。除法律要求外，公司沒有義務在本聲明發布後的修訂或更改中更新這些聲明。</p>
<p><strong>公司聯繫方式</strong></p>
<p>Soren Acquisition Corp.</p>
<p>Arghavan Di Rezze，首席執行官</p>
<p>apd@direzzefamilyoffice.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk1qSXpOeU0zTkRVM05UY3hJelV3TURFMU5qZzNNdz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk1qSXpOeU0zTkRVM05UY3hJelV3TURFMU5qZzNNdz09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png"/></p>

SORNU

<p>Soren Acquisition Corp. 宣佈，從 2026 年 2 月 27 日起，其首次公開募股單位的持有者可以單獨交易 A 類普通股和可贖回認股權證。A 類股票將在納斯達克全球市場以 “SORN” 符號交易，認股權證則以 “SORNW” 符號交易。該公司專注於醫療保健收購，由首席執行官 Arghavan Di Rezze 和首席財務官 Jamie Weber 領導。此公告不構成出售證券的要約</p>

<p>Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (Nasdaq: SORNU) (the “ <strong>Company</strong>”) announced today that, commencing February 27, 2026, the holders of the units issued in the Company’s initial public offering (the “ <strong>Units</strong>”), each consisting of one Class A ordinary share of the Company, par value $0.0001 per share (the “ <strong>Class A Ordinary Shares</strong>”), and one-third of one redeemable warrant of the Company (each, a “ <strong>Warrant</strong>”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and the Warrants will trade on the Nasdaq Global Market under the symbols “SORN” and “SORNW,” respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol “SORNU.”</p>
<div class="lb-trans"><p>邁阿密，佛羅里達州，2026 年 2 月 26 日（全球新聞通訊社）——Soren Acquisition Corp.（納斯達克代碼：SORNU）（以下簡稱 “公司”）今天宣佈，自 2026 年 2 月 27 日起，公司首次公開募股中發行的單位（以下簡稱 “單位”）的持有者，每個單位由一股面值為 0.0001 美元的公司 A 類普通股（以下簡稱 “A 類普通股”）和三分之一的可贖回認股權證（每個稱為 “認股權證”）組成，持有者可以選擇單獨交易單位中包含的 A 類普通股和認股權證。分離單位時不會發行任何零碎的認股權證，只有完整的認股權證可以交易。A 類普通股和認股權證將在納斯達克全球市場上分別以 “SORN” 和 “SORNW” 作為交易代碼進行交易。未分離的單位將繼續在納斯達克全球市場上以 “SORNU” 作為交易代碼進行交易。</p>
</div><p>BTIG, LLC acted as sole book-running manager for the offering.</p>
<div class="lb-trans"><p>BTIG, LLC 擔任此次發行的唯一賬簿管理人。</p>
</div><p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>
<div class="lb-trans"><p>本新聞稿不構成出售公司證券的要約或購買證券的邀請，也不應在任何州或司法管轄區內進行這些證券的銷售，若該要約、邀請或銷售在任何此類州或司法管轄區內在未註冊或未獲得資格的情況下是非法的。</p>
</div><p><strong>About Soren Acquisition Corp.</strong></p>
<div class="lb-trans"><p><strong>關於 Soren Acquisition Corp.</strong></p>
</div><p>The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business within the healthcare industry.</p>
<div class="lb-trans"><p>公司是一家空白支票公司，成立的目的是進行與一個或多個企業的合併、聯合、股份交換、資產收購、股份購買、重組或類似的商業組合。公司可以在任何業務或行業或其公司發展階段追求收購機會，但專注於與醫療行業內具有吸引力的目標企業完成商業組合。</p>
</div><p>The Company’s management team is led by Arghavan Di Rezze, its Chief Executive Officer, and Jamie Weber, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “ <strong>Board</strong>”). In addition, the Board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol. Peter Ondishin and Nicholas Shekerdemian serve as advisors to the Company.</p>
<div class="lb-trans"><p>公司的管理團隊由首席執行官 Arghavan Di Rezze 和首席財務官 Jamie Weber 領導，他們都是公司董事會（以下簡稱 “董事會”）的成員。此外，董事會還包括 Marc Mazur、Charles N. Khan III 和 Spencer Gerrol。Peter Ondishin 和 Nicholas Shekerdemian 擔任公司的顧問。</p>
</div><p><strong>FORWARD-LOOKING STATEMENTS</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明</strong></p>
</div><p>This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“ <strong>SEC</strong>”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.</p>
<div class="lb-trans"><p>本新聞稿可能包含，並且公司代表不時作出的口頭聲明可能包含，根據 1933 年證券法第 27A 條及 1934 年證券交易法第 21E 條的定義的 “前瞻性聲明”。關於可能的商業組合及其融資的聲明，以及本新聞稿中包含的所有其他非歷史事實的聲明均為前瞻性聲明。當在本新聞稿中使用 “預期”、“相信”、“繼續”、“可能”、“估計”、“期望”、“打算”、“可能”、“計劃”、“潛在”、“預測”、“項目”、“應該”、“會” 等詞語時，均與我們或我們的管理團隊相關，標識前瞻性聲明。這些前瞻性聲明基於管理層的信念，以及公司管理層所做的假設和當前可用的信息。實際結果可能因某些因素而與前瞻性聲明所設想的結果有實質性差異，這些因素在公司向證券交易委員會（“SEC”）提交的文件中有詳細説明。所有後續的書面或口頭前瞻性聲明，歸因於我們或代表我們行事的人，均完全受本段的限制。前瞻性聲明受多種條件的制約，其中許多超出了公司的控制，包括在公司向 SEC 提交的首次公開募股註冊聲明和招股説明書的風險因素部分中列出的條件。除法律要求外，公司沒有義務在本聲明發布後的修訂或更改中更新這些聲明。</p>
</div><p><strong>Company Contact</strong></p>
<div class="lb-trans"><p><strong>公司聯繫方式</strong></p>
</div><p>Soren Acquisition Corp.</p>
<div class="lb-trans"><p>Soren Acquisition Corp.</p>
</div><p>Arghavan Di Rezze, Chief Executive Officer</p>
<div class="lb-trans"><p>Arghavan Di Rezze，首席執行官</p>
</div><p>apd@direzzefamilyoffice.com</p>
<div class="lb-trans"><p>apd@direzzefamilyoffice.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk1qSXpOeU0zTkRVM05UY3hJelV3TURFMU5qZzNNdz09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTY2MjIzNyM3NDU3NTcxIzUwMDE1Njg3Mw=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png" alt="" original-src="https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png"/></p>

Soren Acquisition Corp.宣佈其 A 類普通股和認股權證將於2026年2月27日開始分開交易 | SORN 股票新聞